Marshall Wace
SUPN icon

Marshall Wace’s Supernus Pharmaceuticals SUPN Stock Holding History

Marshall Wace’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-51,139
Closed -$1.59M – 2994
2024
Q3 		$1.59M Sell
51,139
-22,380
-30% -$698K ﹤0.01% 1451
2024
Q2 		$1.97M Buy
+73,519
New +$2.13M ﹤0.01% 1377
2022
Q1 		– Sell
-58,078
Closed -$1.7M – 3992
2021
Q4 		$1.7M Buy
+58,078
New +$1.76M ﹤0.01% 2147
2021
Q3 		– Sell
-74,552
Closed -$2.29M – 3416
2021
Q2 		$2.29M Sell
74,552
-44,057
-37% -$1.35M 0.01% 1334
2021
Q1 		$3.1M Buy
118,609
+17,500
+17% +$489K 0.01% 1093
2020
Q4 		$2.54M Sell
101,109
-66,028
-40% -$1.42M 0.01% 855
2020
Q3 		$3.48M Sell
167,137
-253,963
-60% -$5.76M 0.02% 639
2020
Q2 		$10M Buy
421,100
+139,931
+50% +$3.09M 0.07% 284
2020
Q1 		$5.06M Sell
281,169
-38,494
-12% -$809K 0.05% 379
2019
Q4 		$7.58M Sell
319,663
-316,085
-50% -$7.68M 0.05% 383
2019
Q3 		$17.5M Buy
635,748
+77,045
+14% +$2.28M 0.14% 171
2019
Q2 		$18.5M Sell
558,703
-74,027
-12% -$2.54M 0.15% 145
2019
Q1 		$22.2M Buy
632,730
+208,766
+49% +$7.77M 0.21% 102
2018
Q4 		$14.1M Buy
423,964
+418,904
+8,279% +$18M 0.14% 173
2018
Q3 		$255K Buy
+5,060
New +$250K ﹤0.01% 1030
2016
Q2 		– Sell
-31,747
Closed -$484K – 1158
2016
Q1 		$484K Sell
31,747
-142,766
-82% -$1.86M ﹤0.01% 850
2015
Q4 		$2.35M Buy
+174,513
New +$2.7M 0.02% 529

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Marshall Wace's SUPN Position: Q4 2024 in Review

Marshall Wace sold out of Supernus Pharmaceuticals (SUPN) in Q4 2024, closing a stake of 51,139 shares — an estimated $1.59M sold.

Marshall Wace first reported a position in SUPN in Q4 2015 and held it in 17 quarters. The position peaked at $22.2M in Q1 2019. 294 funds tracked by Wall St. Rank hold SUPN as of Q4 2024.

  • Marshall Wace reported no remaining Supernus Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Marshall Wace sold 51,139 Supernus Pharmaceuticals shares in Q4 2024, an estimated $1.59M.
  • Marshall Wace first reported a position in Supernus Pharmaceuticals in Q4 2015 and held it in 17 quarters.
  • Marshall Wace's Supernus Pharmaceuticals position peaked at $22.2M in Q1 2019.
  • 294 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2024.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.